left-caret
Image: Steven Hsu

Steven Hsu

Partner, Corporate Department

Overview

Steven Hsu is a partner in the corporate practice of Paul Hastings and is based in the Hong Kong office.


Mr. Hsu's practice focuses on corporate finance and capital markets transactions, including initial public offerings (IPO) in Hong Kong and the U.S., dual primary and secondary listings, and rights offerings. He has advised on some of the most high-profile IPOs of leading Chinese companies, with a particularly strong track record in sectors such as technology, financial services, consumer goods, life sciences, real estate, and infrastructure. Steven is also highly experienced in advising listed companies on corporate governance and regulatory compliance matters. He was recognized as a "Rising Star of the Year" by IFLR Asia Pacific Awards in 2019.


Mr. Hsu is a native Mandarin speaker and is fluent in English.

Recognitions

  • IFLR Asia Pacific Awards, Rising Star of the Year (2019)
  • Rising Star in International Law Firms ‐ China Business Law Journal 2023 

Education

  • Fordham University School of Law, J.D., 2010
  • Boston University School of Law, LL.M., 2006
  • National Chengchi University, LL.B., 2005

Representations

  • Sponsors/underwriters on the US$1.8 billion Hong Kong primary listing and U.S. SEC-registered offering of XPeng Inc., the first smart electric vehicle producer to complete a dual primary listing in Hong Kong and the U.S.
  • Sponsors/underwriters on the US$72.7 million Hong Kong IPO and U.S. SEC-registered offering of Miniso. It marked the first consumer and retail company to have completed a dual primary listing in Hong Kong.
  • Sponsors/underwriters on the US$1.27 billion Hong Kong secondary listing and U.S. SEC-registered offering of ZTO Express, a leading express delivery company in China.
  • Sponsors/underwriters on HK$1 billion global offering of ANE (Cayman) Inc., a leading express freight network operator in China’s less-than-truckload market, and its listing on the Main Board of the Hong Kong Stock Exchange.
  • Sponsors/underwriters on the US$424 million initial public offering of Ganfeng Lithium, the world’s leading lithium ecological enterprise, and its listing on the Main Board of the Hong Kong Stock Exchange.
  • Underwriters on the US$100 million NASDAQ listing of 111, Inc., a leading digital and mobile healthcare platform in China.
  • Nongfu Spring, a leader in China’s packaged drinking water and beverage segment, on its US$1.08 billion global offering and listing on the Main Board of the Hong Kong Stock Exchange. 
  • Yum China, the largest restaurant company in China in terms of system sales, on the voluntary conversion of its secondary listing status to a primary listing status on the Main Board of the Hong Kong Stock Exchange.
  • Baozun Inc., a leader and pioneer in the brand e-commerce service industry in China, on the voluntary conversion of its secondary listing status to a primary listing status on the Main Board of the Hong Kong Stock Exchange.
  • China Feihe, China’s largest and best-known infant milk formula maker, on its US$856 million global offering and listing on the Main Board of the Hong Kong Stock Exchange. 
  • Sponsors/underwriters on the US$1.38 billion initial public offering of Tigermed, a leading clinical contract research organization in China, and its listing on the Main Board of the Hong Kong Stock Exchange.
  • Sponsors/underwriters on the US$791 million initial public offering of Ming Yuan Cloud, a leading ERP solutions and SaaS products provider for real estate industry participants in China, and its listing on the Main Board of the Hong Kong Stock Exchange.
  • Sponsors/underwriters on the US$329 million initial public offering of China Merchants Commercial REIT, which owns and invests primarily in high quality income-generating commercial properties in China, and its listing on the Main Board of the Hong Kong Stock Exchange.
  • Sponsors/underwriters on the US$1.5 billion initial public offering of China Merchants Securities, a leading securities firm in China, and its listing on the Main Board of the Hong Kong Stock Exchange.
  • China Tower on its US$6.9 billion global offering and listing on the Main Board of the Hong Kong Stock Exchange. It marked one of the world’s largest IPOs in 2018. 
  • Guotai Junan Securities on its US$2.1 billion global offering and listing on the Main Board of the Hong Kong Stock Exchange. It marked the largest Hong Kong IPO in 2017. 
  • China Huarong Asset Management on its US$2.3 billion global offering and listing on the Main Board of the Hong Kong Stock Exchange. It marked the third-largest Hong Kong IPO in 2015.
  • China Everbright Bank on its US$3 billion global offering and listing on the Main Board of the Hong Kong Stock Exchange. It marked the largest Hong Kong IPO in 2013.
  • Jintian Pharmaceutical Group Limited on its HK$2.1 billion global offering and listing on the Main Board of the Hong Kong Stock Exchange.
  • Sponsors/underwriters on the HK$1.2 billion initial public offering of Hengshi Mining Investments Limited and its listing on the Main Board of the Hong Kong Stock Exchange.
  • Sponsors/underwriters on the US$1.4 billion initial public offering of Shengjing Bankand its listing on the Main Board of the Hong Kong Stock Exchange.
  • BOCOM International on its HK$2.1 billion global offering and listing on the Main Board of the Hong Kong Stock Exchange.
  • Sponsors/underwriters on the HK$1.176 billion initial public offering of Inner Mongolia Energy Engineering Co., Ltd, and its listing on the Main Board of the Hong Kong Stock Exchange.
  • Sponsors/underwriters on the US$422 million initial public offering of Jinshang Bank and its listing on the Main Board of the Hong Kong Stock Exchange.
  • Sponsors/underwriters on the HK$1.18 billion initial public offering of Changsha Broad Homes Industrial Group Co., Ltd. and its listing on the Main Board of the Hong Kong Stock Exchange.
  • Sponsors/underwriters on the HK$94.6 billion initial public offering of Evergrande Property Services and its listing on the Main Board of the Hong Kong Stock Exchange.
  • Sponsors/underwriters on the US$600 million initial public offering of Fosun Pharma and its listing on the Main Board of the Hong Kong Stock Exchange.
  • Sponsors/underwriters on the HK$13.8 billion initial public offering of China Energy Engineering Group Co. Ltd. and its listing on the Main Board of the Hong Kong Stock Exchange. 
  • Morgan Stanley, CICC and China Securities International as underwriters on the HK$820.3 million global offering and listing of Shiyue Daotian Group Co., Ltd., a leading and rapidly growing pantry staple food company in China, on the Main Board of the Hong Kong Stock Exchange.
  • Morgan Stanley and CICC as the joint sponsors on the HK$238.9 million global offering and listing of Beisen, the largest provider of cloud-based human capital management (HCM) solutions in China in terms of revenues in 2021, on the Main Board of the Hong Kong Stock Exchange.

Involvement

  • Hong Kong Registered Foreign Lawyer (USA)
  • New York Bar

Practice Areas

Corporate

Securities and Capital Markets


Languages

Chinese (Mandarin)

English


Admissions

Hong Kong Registered Foreign Lawyer (USA)

New York Bar


Education

Fordham University School of Law, J.D. 2010

Boston University School of Law, LL.M. 2006

National Chengchi University, LL.B. 2005


Get In Touch With Us

Contact Us